Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study

References

• Public Health Agency of CanadaDiabetes in Canada2nd ednOttawa, CanadaPublic Health Agency of Canada2002
   Google Scholar
• OhinmaaAJacobsPSimpsonSJohnsonJAThe projection of prevalence and cost of diabetes in Canada: 2000 to 2016Canadian Journal of Diabetes2004282116123
   Google Scholar
• WildSRoglicGGreenASicreeRKingHGlobal prevalence of diabetes: estimates for the year 2000 and projections for 2030Diabetes Care2004271047105315111519
   PubMed Web of Science ®Google Scholar
• Idf.org. [homepage on the internet]. International Diabetes Federation. Diabetes Atlas: Executive Summary. 2003. Second edn. Available from http://www.idf.org/e-atlas Accessed September 15, 2006.
   Google Scholar
• UKPDSIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupLancet19983528378539742976
   PubMed Web of Science ®Google Scholar
• KorytkowskiMWhen oral agents fail: practical barriers to starting insulinInt J Obes Relat Metab Disord2002263S182412174319
   PubMed Web of Science ®Google Scholar
• ZambaniniANewsonRBMaiseyMFeherMDInjection related anxiety in insulin-treated diabetesDiabetes Res Clin Pract19994623924610624790
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRLauritzenTResistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) studyDiabetes Care2005282673267916249538
   PubMed Web of Science ®Google Scholar
• CappelleriJCGerberRAKouridesIAGelfandRADevelopment and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetesDiabetes Care2000231799180311128356
   PubMed Web of Science ®Google Scholar
• PolonskyWHFisherLGuzmanSVilla-CaballeroLEdelmanSVPsychological insulin resistance in patients with type 2 diabetes: the scope of the problemDiabetes Care2005282543254516186296
   PubMed Web of Science ®Google Scholar
• ClementSStillJGKosuticGMcAllisterRGOral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2Diabetes Technol Ther2002445946612396740
   PubMedGoogle Scholar
• CefaluWTSkylerJSKouridesIAInhaled human insulin treatment in patients with type 2 diabetes mellitusAnn Intern Med200113420320711177333
   PubMed Web of Science ®Google Scholar
• HayesRPMuchmoreDSchmitkeJEffect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetesCurr Med Res Opin20072343544217288697
   PubMed Web of Science ®Google Scholar
• BaumanAEFardyHJHarrisPG2003 Getting it right: why bother with patient-centred careMed J Aust200317925325612924973
   PubMed Web of Science ®Google Scholar
• FunnellMMAndersonRMMSJAMA: the problem with compliance in diabetesJAMA2000284170911015809
   PubMed Web of Science ®Google Scholar
• HayesRPBowmanLMonahanPOUnderstanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordanceDiabetes Educ20063240441416772656
   PubMed Web of Science ®Google Scholar
• KrugerDFTying it all together: matching insulin regimens to individual patient needsDiabetes Educ200733491S95S17485417
   PubMed Web of Science ®Google Scholar
• VermeireEHearnshawHVan RoyenPDenekensJPatient adherence to treatment: three decades of research. A comprehensive reviewJ Clin Pharm Ther20012633134211679023
   PubMed Web of Science ®Google Scholar
• CefaluWTChantalMDavidsonJFreemantleNGoughSCanovatchelWPatients’ perceptions of subcutaneous insulin in the OPTIMIZE Study: A multicenter follow-Up studyDiabetes Technol Ther200810253818275360
   PubMed Web of Science ®Google Scholar
• SadriHMacKeiganLDLeiterLAEinarsonTRWillingness to pay for inhaled insulin: a contingent valuation approachPharmacoeconomics2005231215122716336016
   PubMed Web of Science ®Google Scholar
• TrochimWMKThe Research Methods Knowledge Base2nd ednCincinnati, OhioAtomic Dog Publishers2001
   Google Scholar
• DukeSSGordon-SosbyKReynoldsKDGramITA study of breast cancer detection practices and beliefs in black women attending public health clinicsHealth Educ Res1994933134210150453
   PubMed Web of Science ®Google Scholar
• KitzingerJQualitative research. Introducing focus groupsBMJ19953112993027633241
   PubMed Web of Science ®Google Scholar
• RabieeFFocus-group interview and data analysisProc Nutr Soc20046365566015831139
   PubMed Web of Science ®Google Scholar
• KaplowitzMDHoehnJPDo focus groups and individual interviews reveal the same information for natural resource valuationEcological Economics200136237247
   Web of Science ®Google Scholar
• GiacominiMKCookDJUsers’ guides to the medical literature: XXIII. Qualitative research in health care B. What are the results and how do they help me care for my patients? Evidence-Based Medicine Working GroupJAMA200028447848210904512
   PubMed Web of Science ®Google Scholar
• KruegerRFocus Groups: A Practical Guide for Applied ResearchThousand Oaks, CASage Publications1994
   Google Scholar
• LewisMFocus group interviews in qualitative research: A review of the literatureAction Research E-Reports2000
   Google Scholar
• SummersKHSzeinbachSLLenoxSMPreference for insulin delivery systems among current insulin users and nonusersClin Ther2004261498150515531012
   PubMed Web of Science ®Google Scholar
• FreemantleNBlondeLDuhotDAvailability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetesDiabetes Care20052842742815677807
   PubMed Web of Science ®Google Scholar
• HuntLMValenzuelaMAPughJANIDDM patients’ fears and hopes about insulin therapy. The basis of patient reluctanceDiabetes Care1997202922989051375
   PubMed Web of Science ®Google Scholar
• MeeceJDispelling myths and removing barriers about insulin in type 2 diabetesDiabetes Educ2006329S18S16439485
   PubMed Web of Science ®Google Scholar
• PenckoferSFerransCEVelsor-FriedrichBSavoySThe psychological impact of living with diabetes: women’s day-to-day experiencesDiabetes Educ20073368069017684169
   PubMed Web of Science ®Google Scholar
• KorytkowskiMBellDJacobsenCSuwannasariRA multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClin Ther2003252836284814693308
   PubMed Web of Science ®Google Scholar
• Nihgov [homepage on the internet] National Institutes of Health For Safety, NHLBI Changes Intensive Boold Sugar Treatment Strategy in Clinical Trial of Diabetes and Cardiovascular Disease. U.S Department of Health and Human Services – National institutes of Health (NIH) Available from: www.nih.gov/news/health/feb2008/nhlbi-06.htm). Accessed February 26, 2008.
   Google Scholar